SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Oracle Enhances AI Agent Studio with Major New Features
- Logically Introduces Game-Changing Innovations at LogicON 2025
- Groundbreaking Robotic Liver Transplant Offers Hope and Innovation
- Studiosity Named CODiE Awards Finalist for Innovative Solutions
- Rezolute, Inc. Preparing for Key Investor Events in Health Care
- MiMedx Group Set to Unveil Q3 2025 Results in Late October
- Vita Coco's Upcoming Third Quarter Financial Results Announcement
- Amarin Announces Q3 2025 Results with Upcoming Conference Call
- Discover How Adageis is Changing Patient Care with AI Insights
- Angela Robinson Takes the Helm as Director of Product Innovation
- Abacus Global Management Announces Q3 2025 Financial Results
- Innovation Growth Partners Specialty: A New Era in Insurance
- Marex Directors and Officers Boosting Share Holdings Amid Growth
- AtlasClear Holdings Secures Significant Financing to Expand
- AlphaTON Capital Champions Innovation at TOKEN2049 Hackathon
- Absci's Upcoming KOL Webinar on ABS-201 Program Insights
- Progressive Corporation Reveals Strong Results for September 2025
- Innovative Partnership Enhances Fairness in Credit Scoring
- Monopar Therapeutics to Present Groundbreaking Research at AASLD
- Absci's ABS-201: Transforming Alopecia Treatment and Research
- Headwater Gold Partners with OceanaGold for Major Projects
- Revolutionizing Time Synchronization: Microchip's SkyWire Technology
- Gildan Activewear Set to Release Q3 2025 Financial Insights
- The Chefs’ Warehouse Set to Reveal Q3 Results This Month
- CTERA's Intelligent Data Platform Now Accessible via AWS
- Extendicare Declares Regular Dividend, Investing in Seniors' Care
- Harsco Environmental Partners with Jindal for Sustainable Growth
- Current Trends in Cryptocurrency: Bitcoin and Others Stabilize
- Unlocking the Power of Event-Driven Architecture with Kong
- Belite Bio's Groundbreaking Move on Stargardt Disease Treatment
- Thumzup Media Corporation's Innovative Plans with Dogecoin
- Netwrix Enhances Security Solutions to Tackle AI Threats Effectively
- Exploring New Frontiers: Headwater Gold Partners with OceanaGold
- Karooooo Ltd Faces Market Pressures Amid Earnings Report
- Transforming Talent Acquisition with Oracle's AI-Powered Solutions
- Calian Group Partners with Ottawa Airport for Security Solutions
- Navigating Holiday Spending Trends Amid Economic Challenges
- Siguler Guff Secures $29.9M Financing for Luxury Apartments
- Gildan Activewear Sets Date for Q3 2025 Financial Update
- Ferrellgas Plans Senior Notes Offering of $650 Million
- Kong Launches Innovative Billing Solution for Digital Services
- Trulieve Cannabis Corp: Insights Into Q3 2025 Results
- Innovative Deployment of SurgiField System in Conflict Zones
- Atossa Therapeutics Invites Investors to Maxim Growth Summit
- Kong Inc. Enhances API Management with New AWS Integration
- Brock McKinley's Promotion Marks New Era for Grow Capital
- GYMGUYZ Expands Global Reach with Major Middle East Initiative
- Targa Exploration Unveils Insights from Latest Drill Program
- Peet's Coffee Unveils Limited Collaboration with Woolrich
- Hillenbrand Forms Strategic Partnership with Lone Star for Acquisition